Nanjing Yaosheng Pharmaceutical Technology

Nanjing Yaosheng Pharmaceutical Technology is a specialized pharmaceutical research and development company headquartered in Nanjing, China. Founded in 2015, the firm focuses on the development, technical transfer, and consistency evaluation of high-end generic drugs and improved new drugs. The company maintains a strong expertise in small molecule formulation, particularly in the areas of gastroenterology, cardiovascular disease, and anti-infectives. Yaosheng provides comprehensive CRO services to the Chinese pharmaceutical industry, including CMC (Chemistry, Manufacturing, and Controls) development and bioequivalence study management. Its portfolio features several proton pump inhibitors and cardiovascular medications that have successfully navigated the Chinese regulatory landscape. The company operates as a key technical partner for domestic manufacturers seeking to upgrade their product quality to meet modern standards.